- 24/7 Wall St.•14 hours ago
Express Scripts, Teva Pharmaceuticals, Range Resources, and Nielsen posted new 52-week lows on Tuesday.
- TheStreet.com•15 hours ago
It is being reported that Teva will lose its CFO.
- Reuters•16 hours ago
The chief financial officer of Teva Pharmaceutical Industries (TEVA.TA), Eyal Desheh, is stepping down and will likely be appointed chairman of Isracard, Bank Hapoalim's (POLI.TA) credit card company, Israeli news websites reported on Tuesday. Desheh joined Teva as CFO in 2008 and briefly served as acting CEO from October 2013 to February 2014. Teva was left without a permanent chief executive in February after Erez Vigodman stepped down, leaving new management to restore confidence in the world's biggest generic drugmaker after a series of missteps.
TEVA : Summary for Teva Pharmaceutical Industries - Yahoo Finance
Teva Pharmaceutical Industries Limited (TEVA)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||30.22 - 31.40|
|52 Week Range||30.22 - 56.91|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||439.43|
|Dividend & Yield||1.36 (4.23%)|
|1y Target Est||N/A|